Skip to main content

Exact Sciences to Participate in September Investor Conferences

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

  • Wells Fargo Healthcare Conference, Boston

    Fireside chat on Wednesday, September 3, 2025 at 1:30 p.m. ET
  • Baird Global Healthcare Conference, New York

    Fireside chat on Tuesday, September 9, 2025 at 10:50 a.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences helps patients and health care providers make timely, informed decisions before, during, and after a cancer diagnosis. The company’s growing portfolio includes well-established brands such as Cologuard® and Oncotype DX®, along with innovative solutions like Oncodetect™ for molecular residual disease and recurrence monitoring. Exact Sciences continues to invest in a robust pipeline of advanced cancer diagnostics aimed at improving outcomes. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.95
-4.08 (-1.84%)
AAPL  257.50
-5.27 (-2.01%)
AMD  228.65
-9.38 (-3.94%)
BAC  51.00
-0.52 (-1.01%)
GOOG  252.45
+1.11 (0.44%)
META  732.44
-0.83 (-0.11%)
MSFT  519.69
+2.03 (0.39%)
NVDA  179.42
-1.74 (-0.96%)
ORCL  273.94
-1.20 (-0.44%)
TSLA  437.44
-5.16 (-1.17%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.